Psychedelic Therapy: What Pharmacists Need to Know Before MDMA and Psilocybin Approvals
- 0:00 Why Pharmacists Need In
- 7:00 Therapy Models And Pathways
- 17:00 Evidence Snapshot By Indication
Practical shifts you can apply this week
-
Identify Care Pathways
Map where pharmacists fit across prep, dosing, monitoring, and follow-up in MDMA and psilocybin care.
-
Evaluate Evidence And Safety
Weigh trial strengths, limits, and risk signals with a pharmacist's eye for real-world decisions.
-
Compare Regulatory Requirements
Prepare for likely storage, custody, documentation, and controlled-substance constraints before launch.
-
Diagnose Medication Risks
Spot interactions, contraindications, and continuity issues that can complicate time-limited treatment episodes.
-
Design A Readiness Plan
Leave with a practical framework for policy, education, workflow, and safety monitoring in your setting.
What we'll cover
-
0:00
Why Pharmacists Need In
Why this matters now, where pharmacists enter the model, and why psychedelic care does not behave like routine prescribing.
-
7:00
Therapy Models And Pathways
Walk through prep-session-dose-integration flows, site-of-care logistics, and role splits across teams.
-
17:00
Evidence Snapshot By Indication
Review MDMA in PTSD and psilocybin in depression, including effect size, durability, and what trial design muddies.
-
28:00
Safety Signals That Matter
Focus on psychiatric screening, cardiovascular concerns, serotonergic overlap, and escalation thresholds.
-
39:00
Regulatory And Supply Realities
Cover FDA versus access in practice, DEA issues, storage, chain of custody, and product standardization limits.
-
49:00
Medication Management Across Episodes
Work through washouts, tapers, peri-session medication choices, and continuity of care after treatment.
-
56:00
Readiness Plan And Q&A
Recap the 90-day checklist, pick one gap to own, and bring your practical questions.
Questions people ask before registering
-
It is built for pharmacists and pharmacy leaders in institutional, ambulatory, specialty, and behavioral health settings. Other clinicians are welcome, but the lens stays firmly on pharmacy practice.
-
No. We start with the care model and key terms, then move into evidence, safety, and operations. If you know medication management, you will be able to follow the discussion.
-
Yes. The session includes storage, documentation, chain of custody, medication review, and readiness planning. Think less abstract debate, more what your team may need to decide next.
-
Most webinar programs provide a replay after the event, but availability depends on the host's setup. Registering is the safest way to receive any follow-up details.
-
Any certificate or CE availability is determined by the webinar host, not assumed here. Check the registration page for the official accreditation details and requirements.